Theresa R. Cerulli, MD: The neuroscience of ADHD is fascinating…The neuroscience of ADHD, I’ll break it into 4 categories. Think about the genetics, the neuroanatomy, the neural networks, and neurotransmitters that are involved. We know that these objective measures have shown that there are differences in those 4 areas between children and adults with ADHD…

KEY POINTS: It is the brain’s job to filter and make sense of the firehose of stimuli, internal and external, from which we drink every moment. ADHD is common, affecting nearly 10% of children and over 10 million adults. Mindfulness-based approaches in clinical studies and practice have utility in alleviating ADHD symptoms by targeting core…

The premise that one’s space reflects one’s mental health can be particularly defeating if you’re already in a bad place mentally or physically…The shame of having a home that fails to meet society’s standards can paralyze, and often silence, people who need help managing clutter.

Raising awareness of attention deficit hyperactivity disorder (ADHD) helps create welcoming, accessible schools and workplaces. It also ensures doctors can properly treat ADHD, reduces the impact of the condition, and may encourage people with symptoms of ADHD to seek a diagnosis…During ADHD Awareness Month, organizations such as Children and Adults with ADD (CHADD) host educational…

Care management in addition to use of an online patient portal was not found to improve communication or outcomes among children with attention-deficit/hyperactivity disorder (ADHD) compared with use of the portal alone, according to the results of a randomized controlled trial published in Pediatrics.

For children with attention-deficit/hyperactivity disorder (ADHD), supplementation was micronutrients was found to have global benefits including height growth. These findings, from a placebo-controlled, randomized trial, were published in the Journal of the American Academy of Child & Adolescent Psychiatry.

The US Food and Drug Administration has approved Tris Pharma’s Dyanavel XR (amphetamine), extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years and older…Dyanavel XR is a central nervous system stimulant prescription medicine used for the treatment of ADHD in individuals aged 6 years and older.

According to recent research, about 50% of patients with attention-deficit/hyperactivity disorder (ADHD) also develop oppositional defiant and conduct disorder (ODD/CD).1 Additionally, callous-unemotional (CU) traits—including reduced guilt and remorse, callousness, low empathy, and deficient prosocial emotions—overlap with the dimensions of ADHD and ODD/CD symptoms.

“It’s important that from day 1 we see the patient, we are looking for comorbidities,” said Napoleon B. Higgins, Jr, MD, at the 2021 NEI Congress in his talk “There’s More to It: ADHD and Comorbidities”…More than 50% of individuals with ADHD have comorbid disorders. Comorbid conditions include learning and language disabilities, mood disorders like…

A study of about 11,000 dogs conducted at the University of Helsinki found that gender, age, Dog breeds and behavioral problems and certain environmental factors are associated with hyperactivity and impulsive behavior and inattention (ADHD).

You have to do your research and see what makes each medication different from its counterpart and why. For starters, stimulants have been around longer, which means there is more research on and more knowledge about this type of treatment…Take a look at the guide below to learn more about each type of medication and…

KEY POINTS: Adults who have undiagnosed or untreated ADHD often struggle with anxiety and depression. What seem like other mental problems are often byproducts of the ADHD itself. The keys to managing ADHD are developing good organizational skills and considering medication.